Best tolerated dose of Pirfenidone in patients with idiopathic pulmonary fibrosis
N. Agrawal (Vashi, Navi Mumbai, India), P. Vaidya (Vashi, Navi Mumbai, India), V. Chavhan (Vashi, Navi Mumbai, India), T. Lele (Vashi, Navi Mumbai, India), A. Leuppi-Taegtmeyer (Liestal, Switzerland), J. Leuppi (Liestal, Switzerland), P. Chhajed (Vashi, Navi Mumbai, India)
Source: International Congress 2019 – Interstitial lung disease registries
Session: Interstitial lung disease registries
Session type: Thematic Poster
Number: 4707
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Agrawal (Vashi, Navi Mumbai, India), P. Vaidya (Vashi, Navi Mumbai, India), V. Chavhan (Vashi, Navi Mumbai, India), T. Lele (Vashi, Navi Mumbai, India), A. Leuppi-Taegtmeyer (Liestal, Switzerland), J. Leuppi (Liestal, Switzerland), P. Chhajed (Vashi, Navi Mumbai, India). Best tolerated dose of Pirfenidone in patients with idiopathic pulmonary fibrosis. 4707
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: